Your email has been successfully added to our mailing list.

×
0 0 0 0 0.00125488008923597 0.000557724484104939 0.000418293363078655 0.00125488008923597
Stock impact report

Sun Pharma latest to sell COVID-19 drug favipiravir in India [Reuters]

Gilead Sciences, Inc. (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
Company Research Source: Reuters
Sun Pharma latest to sell COVID-19 drug favipiravir in India BENGALURU (Reuters) - India’s Sun Pharmaceutical Industries Ltd said on Tuesday it would soon begin selling its version of favipiravir, becoming the latest generic drugmaker to supply the antiviral to treat COVID-19 in the world’s third worst-hit nation. Favipiravir, along with another antiviral, remdesivir, has emerged as one of the most sought-after drugs at hospitals fighting COVID-19 in India, which saw a surge of 50,000-plus infections for the sixth straight day on Tuesday. Sun’s version of favipiravir, to be called FluGuard, will cost 35 rupees (47 cents) per 200 mg tablet, making it the cheapest version available. Stocks will be available from this week. Shares in Sun Pharma, one of the world’s largest generic drug manufacturers, climbed after the news and were last up 1.7% in an upbeat Mumbai market. [.BO] Favipiravir was originally developed by Japan’s Fujifilm Holdings Corp as Avigan. Once hyped as a potential COVI Show less Read more
Impact Snapshot
Event Time:
GILD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for GILD alerts
Opt-in for
GILD alerts

from News Quantified
Opt-in for
GILD alerts

from News Quantified